Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
evandijk70
on Nov 11, 2022
|
parent
|
context
|
favorite
| on:
CRISPR cancer trial success paves the way for pers...
Different treatment, but tumors receptive to EGFR-treatment almost always develop secondary resistance to treatment by additional mutations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367712/
dm319
on Nov 11, 2022
[–]
Yes good point.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367712/